Alexandria Real Estate Equities FFO of $1.57 beats by $0.04, revenue of $671.18M beats by $12.62M (NYSE:ARE)

Alexandria Real Estate Equities reported Q3 FFO of $1.57, exceeding estimates by $0.04, with revenue of $671.18M, beating expectations by $12.62M. The company updated its 2026 guidance to reflect current market conditions.

Original reporting
Published Oct 26, 2026, 8:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ARE
Bullish
high confidence
Mentioned
$ARE
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$AREBullishMed
01

Why it matters

The earnings beat may trigger short‑term buying interest and could influence REIT sector sentiment.

02

Market read

Earnings beat provides a fresh catalyst for ARE and may affect related REITs.

03

What to watch

Potential headwinds from rising interest rates could offset earnings strength.

Relevance 7/10Novelty 7/10Timing: after-hours release

Background

Alexandria Real Estate Equities (ARE) reported Q3 results that beat consensus on both FFO and revenue.

Company-level read

Ticker impact

$AREBullishHigh confidence
Context

Q3 FFO of $1.57 beats consensus by $0.04 and revenue of $671.18M beats by $12.62M, first report of the earnings results.

Expected impact

likely upward pressure as market prices in the earnings beat

Evidence & confidence

Both FFO and revenue exceeded expectations, which typically supports a price rally.

Market effects

Positive earnings may lift other REITs in the office and life‑science space.

U.S. REIT sector could see modest gains.

Limited to U.S. real‑estate markets.

Counterpoint

If guidance for 2026 is muted, the beat may be priced in quickly, limiting upside.

Key entities

  • Alexandria Real Estate Equities, Inc.

    U.S. listed REIT focused on life‑science and office properties.

Related articles

$AREHigh

BofA downgrades Alexandria Real Estate stock rating on earnings concerns

BofA Securities downgraded Alexandria Real Estate Equities (NYSE:ARE) to Underperform, lowering its price target to $45 from $55. The company reported a $8.40 per share loss and 9.77% revenue decline over the last year, despite a 6.5% dividend yield. BofA cited declining earnings and leasing challenges as reasons for the downgrade. Alexandria's Q3 2026 results showed mixed performance, with revenue exceeding estimates but significant earnings loss due to real estate impairments.

$AREMedAI 8/10

Alexandria Real Estate Equities Inc (ARE) (Q3 2026) Earnings Call Highlights: Record

Alexandria Real Estate Equities Inc (ARE) reported Q3 2026 earnings with record leasing of 1.2M sq ft, strong liquidity at $4.6B, and $1.7B in capital raised. However, same-property NOI declined 6.7% (GAAP) due to lower occupancy (87.1%). The company expects temporary occupancy pressure in early 2027 and recognized $638M in impairments. Management discussed development spending, tenant wind-downs, and disposition strategies during the earnings call.

$AREHighAI 8/10

KKR Makes $475M Bet in San Diego's Life Science Market

KKR invested $475M in Alexandria Real Estate Equities' 2M sq ft San Diego life science campus, taking a 49% stake. The joint venture will support leasing and development. Alexandria's CEO called it a step to optimize capital. Tenants include Bristol Myers Squibb and Eli Lilly. KKR has invested $20B in life sciences since 2004.

$AREHighAI 8/10

KKR Acquires 49% Stake in Alexandria Real Estate Equities' Campu

KKR & Co. acquired a 49% stake in Alexandria Real Estate Equities Inc.'s (ARE) Campus Point life science Megacampus for $475 million. ARE retains majority ownership and management control. The company's P/S ratio is 2.35, below its historical median, and it has a GF Score of 61/100, indicating moderate fundamental health with weaknesses in financial strength and valuation.

$AREMedAI 8/10

KKR invests $475m in Alexandria Real Estate Equities’ Campus Point

KKR invested $475m in Alexandria Real Estate Equities' Campus Point, a 2M sq. ft. life sciences campus in San Diego. KKR holds a 49% stake, while Alexandria retains majority ownership. The deal provides Alexandria with capital for development and leasing. Campus Point is home to companies like Novartis.